Janus Henderson Group plc 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:24 am Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
3,562,402 6.100% |
1,724,611 (+93.84%) |
Filing |
| 2023-02-09 11:40 am Sale |
2022-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
1,837,791 4.400% |
-563,102 (-23.45%) |
Filing |
| 2022-02-11 6:30 pm Purchase |
2021-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
2,400,893 5.800% |
2,400,893 (New Position) |
Filing |